U.S. Market on Fire, Surprising Nation Up 10x Since 2025
The U.S. market is blazing, but a surprising nation has surged 10x U.S. stock gains since early 2025. Here's what inv...
Ways To Use Skills For Extra Income
Your skills can be a valuable source of income. Explore ways to use skills for extra income and maximize your earning potential.
20,974 articlesTech Creating National Security Crisis? Pentagon Warns
The Pentagon says commercial data was used to target U.S. service members, a development that could spur tighter data...
DxSale Breach Drains $7.3M From 1,400 Liquidity Providers
A major DeFi breach on the BNB Chain drains $7.3 million from over 1,400 liquidity providers linked to aging DxSale c...
Realtracs Keeps Zillow Listing Feed Alive Through June 8
Realtracs will extend its Zillow data feed through June 8 while ongoing licensing talks address broker compensation a...
Ripple Targets Turkey with RLUSD Stablecoin Push Globally
Ripple expands RLUSD into Turkey, challenging incumbents USDT and USDC as inflation and currency volatility drive dem...
Before Nebius Stock, Make Smarter Risk Checks Right Now
Nebius stock has drawn attention for rapid AI cloud growth, but two core risks could derail momentum. This guide give...
AI-Powered Computer Worm Could Redefine Cyber Threats
Researchers unveil an autonomous AI-driven worm that can learn and spread across networks without human input, signal...
A $10K Investment, $150 Week: Lessons From Leveraged ETFs
A disciplined plan using leveraged ETFs can magnify gains in strong markets, but path dependence and decay risk loom....
Zcash Fallout After Orchard Bug Prompts Hayes Exit From Market
Arthur Hayes liquidated his entire Zcash position after a publicly disclosed Orchard Pool vulnerability. The move und...
XRP Holders Won’t Like What AI Projects Next Moves
An AI-driven forecast in June 2026 warns of potential further weakness for XRP, signaling price targets that could un...
Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status